Organic chemistry News and Research

RSS

TUM experts decipher secrets of Achilles' heel

Walking, running, sprinting -- every movement of the foot stretches the Achilles' tendon. When jumping, the loads can approach ten times the body weight.

28 Feb 2017

UTA chemists developing new synthetic methods to produce compounds for drug discovery

Chemists at The University of Texas at Arlington are developing new methods to synthesize groups of chemical compounds to provide faster, less expensive routes to produce the compounds for subsequent use in medical drug discovery and development.

4 Jan 2017

Researchers develop novel membranes whose selectivity can be tuned dynamically with light

Researchers of Karlsruhe Institute of Technology (KIT) and Uni-versität Hannover developed novel membranes, whose selectivity can be switched dynamically with the help of light.

23 Dec 2016

Scientists synthesize antitumor compound to combat chemoresistant cancer

A team of scientists from N. D. Zelinsky Institute of Organic Chemistry of the Russian Academy of Sciences, N. K. Kol'tsov Institute of Developmental Biology of the RAS, and Immune Pharmaceuticals LLC led by MIPT's Prof. Alexander Kiselyov has synthesized an antitumor compound that could be used to fight chemoresistant cancer.

30 Nov 2016

Researchers find way to make changes to enzyme-driven assembly line to improve antibiotics

Researchers from North Carolina State University have discovered a way to make pinpoint changes to an enzyme-driven "assembly line" that will enable scientists to improve or change the properties of existing antibiotics as well as create designer compounds.

30 Nov 2016

Elucidating IDP behaviour on crowded membranes

IDPs are proteins that contain stretches of amino-acid sequence that are flexible and do not comprise stable structure in isolation. This is in contrast with a more traditional view of proteins as largely occupying a stable native structure that correlates with functions such as enzyme activity or binding.

10 Nov 2016

TPU scientists developing bioactive coating for medical implants

A group of young scientists from Tomsk Polytechnic University are developing a bioactive coating for medical implants. Due to its properties, it will be able to "convince" the body not to reject the artificial bones and joints.

2 Nov 2016

Compound bearing hidden chirality can trigger autocatalytic preparation of chiral organic intermediates

The preparation of chiral compounds as intermediates in drug synthesis is one of the most important targets in synthetic organic chemistry.

20 Oct 2016

New JGU cyclotron to be employed for research into potential applications in medicine

A new particle accelerator is further enhancing the research landscape at Johannes Gutenberg University Mainz.

14 Sep 2016

Chemists find efficient way to convert organic molecules into new medicines

Opening a broad vista in the search for effective pharmaceuticals, a collaboration of Chinese and U.S. chemists has laid out a highly efficient new method to convert abundant organic molecules into new medicines.

2 Sep 2016

Research article outlines utilization of calixarenes in biocatalysis and cancer therapy

Calixarenes bear a fascinating class of macrocycles that have served broadly in molecular recognition and supramolecular chemistry.

17 Aug 2016

Scientists discover way to visualize function of bone-resorbing cells in living mice

Researchers of Osaka University have discovered a way to visualize sites where bone-resorbing cells (osteoclasts) were in the process of resorbing bone in living mice.

17 Aug 2016

Researchers succeed in activating a 'single-molecule switch'

Everybody knows the force that is required to activate a light switch on a wall - a finger is enough. But how much force do you need to apply if the device was dramatically reduced to the "nanoscale world", that is, how much force do you need to operate a "single-molecule switch"? This fundamental question is related not only to basic science but also to potential future applications of molecular devices.

18 Jul 2016

Compounds extracted from parsley and dill seeds may help fight cancer

A team of Russian scientists from Moscow Institute of Physics and Technology, the N. D. Zelinsky Institute of Organic Chemistry, the Institute of Developmental Biology, and the Institute of Cell Biophysics proposed an efficient approach to a novel agents with anticancer activity.

29 Jun 2016

Pittcon 2015: Bruker introduces InsightMR software for on-line NMR analysis of chemical processes

Bruker is launching InsightMR software for on-line NMR analysis of chemical processes at Pittcon 2015. For the first time, a software platform enables the adjustment of experimental parameters based on real time data during the analysis of chemical processes by NMR spectroscopy.

From Bruker BioSpin Group 15 Mar 2016

Researchers uncover antitumoral nature of maslinic acid in colon cancer cells

Researchers from the University of Granada, in collaboration with the universities of Barcelona and Jaen, have brought to light the antitumoral nature of maslinic acid (a compound derived from olives) in Caco-2 p53-deficient colon adenocarcinoma cells in the short term.

11 Mar 2016

Molecular imaging and radiochemistry: the importance of instrumentation. An interview with Professor Björn Wängler

Interview conducted with Professor Björn Wängler, Professor for Molecular Imaging and Radiochemistry from Heidelberg University.

From Bruker BioSpin Group 4 Feb 2016

JGU employs new particle accelerator to enhance research into radiopharmaceutical chemistry

A new particle accelerator will further enhance the research landscape at Johannes Gutenberg University Mainz. It is to be employed to conduct research into potential applications of medical relevance.

5 Jan 2016

UCA researchers identify compounds that favour generation of new neuronal cells

Many neurology pathologies cause irreversible loss of neurons. They are mostly the so-called neurodegenerative diseases although there exist other causes for a focal loss of neurons, as it is the case in strokes or traumatic brain injuries. All these pathologies lack nowadays of an efficient treatment not being possible to regenerate dead neurons. In fact, although the brain has the ability to regenerate as many studies has proved, this regeneration is very low, ranging from 0.2% to a maximum of 10% depending on the type of injury and the damaged area.

17 Dec 2015

WuXi PharmaTech announces winners of Life Science and Chemistry Awards

WuXi PharmaTech (Cayman) Inc., a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology and medical device industries, with operations in China and the United States, announced the winners of the ninth annual WuXi PharmaTech Life Science and Chemistry Awards at a ceremony held on December 13 at Diaoyutai State Guesthouse in Beijing.

14 Dec 2015